Induction of terminal differentiation by constitutive activation of p38 MAP kinase in human rhabdomyosarcoma cells.

MyoD inhibits cell proliferation and promotes muscle differentiation. A paradoxical feature of rhabdomyosarcoma (RMS), a tumor arising from muscle precursors, is the block of the differentiation program and the deregulated proliferation despite MyoD expression. A deficiency in RMS of a factor required for MyoD activity has been implicated by previous studies. We report here that p38 MAP kinase (MAPK) activation, which is essential for muscle differentiation, is deficient in RMS cells. Enforced induction of p38 MAPK by an activated MAPK kinase 6 (MKK6EE) restored MyoD function and enhanced MEF2 activity in RMS deficient for p38 MAPK activation, leading to growth arrest and terminal differentiation. Stress and cytokines could activate the p38 MAPK in RMS cells, however, these stimuli did not promote differentiation, possibly because they activated p38 MAPK only transiently and they also activated JNK, which could antagonize differentiation. Thus, the selective and sustained p38 MAPK activation, which is distinct from the stress-activated response, is required for differentiation and can be disrupted in human tumors.

[1]  C. Arndt,et al.  Common musculoskeletal tumors of childhood and adolescence. , 1999, The New England journal of medicine.

[2]  Jeffrey L. Wrana,et al.  Post-translational control of the MEF2A transcriptional regulatory protein , 1999, Nucleic Acids Res..

[3]  Andrew D. Sharrocks,et al.  Targeting of p38 Mitogen-Activated Protein Kinases to MEF2 Transcription Factors , 1999, Molecular and Cellular Biology.

[4]  H. Ellinger-Ziegelbauer,et al.  Cell Cycle Arrest and Reversion of Ras-Induced Transformation by a Conditionally Activated Form of Mitogen-Activated Protein Kinase Kinase Kinase 3 , 1999, Molecular and Cellular Biology.

[5]  E. Bengal,et al.  p38 Mitogen-activated Protein Kinase Pathway Promotes Skeletal Muscle Differentiation , 1999, The Journal of Biological Chemistry.

[6]  P. Cohen,et al.  Stress-activated Protein Kinase-2/p38 and a Rapamycin-sensitive Pathway Are Required for C2C12 Myogenesis* , 1999, The Journal of Biological Chemistry.

[7]  Jiahuai Han,et al.  Regulation of the MEF2 Family of Transcription Factors by p38 , 1999, Molecular and Cellular Biology.

[8]  J. Engelman,et al.  Specific Inhibitors of p38 Mitogen-activated Protein Kinase Block 3T3-L1 Adipogenesis* , 1998, The Journal of Biological Chemistry.

[9]  H. Arnold,et al.  Muscle differentiation: more complexity to the network of myogenic regulators. , 1998, Current opinion in genetics & development.

[10]  K. Arden,et al.  Elevated cyclins and cyclin-dependent kinase activity in the rhabdomyosarcoma cell line RD. , 1998, Cancer research.

[11]  B. Black,et al.  Multiple Roles for the MyoD Basic Region in Transmission of Transcriptional Activation Signals and Interaction with MEF2 , 1998, Molecular and Cellular Biology.

[12]  L. Kedes,et al.  Differential roles of p300 and PCAF acetyltransferases in muscle differentiation. , 1997, Molecular cell.

[13]  M. Karin,et al.  Molecular cloning and characterization of human JNKK2, a novel Jun NH2-terminal kinase-specific kinase , 1997, Molecular and cellular biology.

[14]  S. Tapscott,et al.  Inactivation of MyoD-mediated expression of p21 in tumor cell lines. , 1997, Cell growth & differentiation : the molecular biology journal of the American Association for Cancer Research.

[15]  M. Karin,et al.  Regulation and function of the JNK subgroup of MAP kinases. , 1997, Biochimica et biophysica acta.

[16]  H. Perlman,et al.  Cell cycle exit upon myogenic differentiation. , 1997, Current opinion in genetics & development.

[17]  M. Cobb,et al.  Mitogen-activated protein kinase pathways. , 1997, Current opinion in cell biology.

[18]  Jiahuai Han,et al.  Activation of the transcription factor MEF2C by the MAP kinase p38 in inflammation , 1997, Nature.

[19]  G. Natoli,et al.  MyoD prevents cyclinA/cdk2 containing E2F complexes formation in terminally differentiated myocytes , 1997, Oncogene.

[20]  J R Florini,et al.  Growth hormone and the insulin-like growth factor system in myogenesis. , 1996, Endocrine reviews.

[21]  P. Houghton,et al.  Alpha 2a-interferon-induced differentiation of human alveolar rhabdomyosarcoma cells: correlation with down-regulation of the insulin-like growth factor type I receptor. , 1996, Cell growth & differentiation : the molecular biology journal of the American Association for Cancer Research.

[22]  R. Davis,et al.  MKK3- and MKK6-regulated gene expression is mediated by the p38 mitogen-activated protein kinase signal transduction pathway , 1996, Molecular and cellular biology.

[23]  Jiahuai Han,et al.  Characterization of the Structure and Function of a Novel MAP Kinase Kinase (MKK6) (*) , 1996, The Journal of Biological Chemistry.

[24]  B. Black,et al.  Cooperative activation of muscle gene expression by MEF2 and myogenic bHLH proteins , 1995, Cell.

[25]  W. Wetsel,et al.  Rapid activation and down-regulation of protein kinase C alpha in 12-O-Tetradecanoylphorbol-13-acetate-induced differentiation of human rhabdomyosarcoma cells. , 1995, Cell growth & differentiation : the molecular biology journal of the American Association for Cancer Research.

[26]  Richard Treisman,et al.  Transcriptional Regulation by Extracellular signals: Mechanisms and Specificity , 1995, Cell.

[27]  C. Marshall,et al.  Specificity of receptor tyrosine kinase signaling: Transient versus sustained extracellular signal-regulated kinase activation , 1995, Cell.

[28]  A. Lassar,et al.  Regulatory mechanisms that coordinate skeletal muscle differentiation and cell cycle withdrawal. , 1994, Current opinion in cell biology.

[29]  S. Alemà,et al.  Oncogenes and muscle differentiation: multiple mechanisms of interference. , 1994, Seminars in cancer biology.

[30]  P. Rigby,et al.  The regulation of myogenin gene expression during the embryonic development of the mouse. , 1993, Genes & development.

[31]  S. Tapscott,et al.  Deficiency in rhabdomyosarcomas of a factor required for MyoD activity and myogenesis. , 1993, Science.

[32]  S. Tapscott,et al.  Monoclonal antibodies to the myogenic regulatory protein MyoD1: epitope mapping and diagnostic utility. , 1992, Cancer research.

[33]  E. Olson,et al.  Interplay between proliferation and differentiation within the myogenic lineage. , 1992, Developmental biology.

[34]  M. Karin,et al.  Fos and Jun repress transcriptional activation by myogenin and MyoD: the amino terminus of Jun can mediate repression. , 1992, Genes & development.

[35]  S. Tapscott,et al.  Functional antagonism between c-Jun and MyoD proteins: A direct physical association , 1992, Cell.

[36]  H. Weintraub,et al.  MyoD induces growth arrest independent of differentiation in normal and transformed cells. , 1990, Proceedings of the National Academy of Sciences of the United States of America.

[37]  R. Pepperkok,et al.  Cell proliferation inhibited by MyoD1 independently of myogenic differentiation , 1990, Nature.

[38]  Jiahuai Han,et al.  Regulation of the MEF 2 Family of Transcription Factors by p 38 † , 1998 .

[39]  David K. C. Jones.  Superficial gain , 1994, Nature.